Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

IRIX Insider Trading

IRIDEX CORP | Electromedical & Electrotherapeutic Apparatus

Comprehensive Trading Performance Summary

The investment history of corporate insiders at IRIDEX CORP provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Electromedical & Electrotherapeutic Apparatus sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2025-06-04 02:18 2025-06-02 Dizon Romeo R Officer - Chief Financial Officer BUY $1.00 200 $199 12,665 +1.6%
2025-05-30 03:10 2025-05-29 Dizon Romeo R Officer - Chief Financial Officer BUY $0.99 200 $197 12,465 +1.6%
2025-05-29 02:28 2025-05-28 Dizon Romeo R Officer - Chief Financial Officer BUY $0.95 200 $190 12,265 +1.7%
2025-05-28 03:01 2025-05-27 Dizon Romeo R Officer - Chief Financial Officer BUY $1.00 100 $100 12,065 +0.8%
2025-05-28 00:21 2025-05-23 Dizon Romeo R Officer - Chief Financial Officer BUY $1.00 100 $100 11,965 +0.8%
2025-05-23 00:05 2025-05-22 Dizon Romeo R Officer - Chief Financial Officer BUY $1.00 200 $201 11,865 +1.7%
2025-05-16 20:38 2025-05-14 MOORE WILLIAM M Director BUY $1.09 17,500 $19,009 138,650 +14.4%
2025-05-16 00:20 2025-05-14 Dizon Romeo R Officer - Chief Financial Officer BUY $1.10 460 $506 11,665 +4.1%
2025-05-14 00:35 2025-05-13 Dizon Romeo R Officer - Chief Financial Officer BUY $1.11 1,305 $1,451 11,205 +13.2%
2025-05-13 00:53 2025-05-12 Dizon Romeo R Officer - Chief Financial Officer BUY $1.16 100 $116 9,900 +1.0%
2025-05-09 23:46 2025-05-09 Dizon Romeo R Officer - Chief Financial Officer BUY $1.15 100 $115 9,800 +1.0%
2025-05-09 00:48 2025-05-08 Dizon Romeo R Officer - Chief Financial Officer BUY $1.15 100 $115 9,700 +1.0%
2025-05-08 01:29 2025-05-07 Dizon Romeo R Officer - Chief Financial Officer BUY $1.15 193 $222 9,600 +2.1%
2025-05-07 00:51 2025-05-06 Dizon Romeo R Officer - Chief Financial Officer BUY $1.17 200 $235 9,407 +2.2%
2025-05-06 01:34 2025-05-05 Dizon Romeo R Officer - Chief Financial Officer BUY $1.19 200 $237 9,207 +2.2%
2025-04-30 22:16 2025-04-28 MOORE WILLIAM M Director BUY $1.21 20,000 $24,144 121,150 +19.8%
2025-04-30 02:42 2025-04-29 Dizon Romeo R Officer - Chief Financial Officer BUY $1.23 3,907 $4,806 9,007 +76.6%
2025-04-29 01:35 2025-04-28 Dizon Romeo R Officer - Chief Financial Officer BUY $1.28 2,625 $3,363 5,100 +106.1%
2025-04-29 00:18 2025-04-24 Mercer Patrick Officer - President and CEO BUY $1.29 7,546 $9,758 400,790 +1.9%
2025-04-25 21:53 2025-04-25 Dizon Romeo R Officer - Chief Financial Officer BUY $1.18 975 $1,151 2,475 +65.0%
2025-04-25 18:39 2025-04-24 Shuda Scott Director BUY $1.20 21,457 $25,748 129,523 +19.9%
2025-04-25 00:51 2025-04-23 Dizon Romeo R Officer - Chief Financial Officer BUY $1.16 1,000 $1,155 1,500 +200.0%
2025-04-24 23:21 2025-04-23 HUSS BEVERLY A Director BUY $1.22 25,900 $31,500 92,639 +38.8%
2025-04-24 02:10 2025-04-21 MOORE WILLIAM M Director BUY $1.07 20,000 $21,372 101,150 +24.6%
2025-04-22 20:00 2025-04-21 Dizon Romeo R Officer - Chief Financial Officer BUY $1.05 500 $525 500 +100.0%
2022-05-24 01:49 2022-05-20 Devi Nandini Director BUY $3.10 2,000 $6,200 10,420 +23.8%
2022-03-16 23:32 2022-03-16 Devi Nandini Director BUY $4.20 2,000 $8,400 8,420 +31.2%
2021-12-03 01:24 2021-12-02 Grove Robert Earle Director BUY $6.08 1,644 $9,999 93,364 +1.8%
2021-11-17 01:56 2021-11-16 Devi Nandini Director BUY $7.73 1,000 $7,730 6,420 +18.5%
2020-05-19 01:32 2020-05-15 Grove Robert Earle Director BUY $1.68 15,125 $25,446 67,952 +28.6%
2019-11-20 00:18 2019-11-18 Grove Robert Earle Director BUY $2.04 14,600 $29,749 52,827 +38.2%
2019-11-16 03:48 2019-11-15 Grove Robert Earle Director BUY $2.02 10,000 $20,187 38,227 +35.4%
2019-11-16 03:37 2019-11-13 Shuda Scott Director BUY $2.02 15,000 $30,251 15,000 +100.0%
2018-12-14 04:59 2018-12-13 Grove Robert Earle Director BUY $4.30 863 $3,711 11,720 +7.9%
2018-12-14 04:55 2018-12-12 MOORE WILLIAM M Director, Officer - Chairman and CEO BUY $4.34 10,000 $43,443 206,800 +5.1%
2018-12-13 02:59 2018-12-10 Grove Robert Earle Director BUY $4.23 10,857 $45,878 10,857 +100.0%
2018-11-28 03:16 2018-11-27 MOORE WILLIAM M Director, Officer - Chairman and CEO BUY $4.71 10,000 $47,144 211,800 +5.0%
2018-09-20 19:27 2018-09-18 PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE Other BUY $6.00 70,000 $420,000 1,320,000 +5.6%
2018-09-18 00:10 2018-09-14 MOORE WILLIAM M Director, Officer - Chairman and CEO BUY $6.56 10,000 $65,600 201,800 +5.2%
2018-05-02 00:01 2017-08-16 Acuta Capital Fund, LP 10% owner BUY $8.43 2,996 $25,249 1,344,720 +0.2%
2018-05-01 23:59 2017-07-03 Acuta Capital Fund, LP 10% owner BUY $9.15 184,713 $1,689,884 1,341,724 +16.0%
2018-03-14 23:12 2018-03-13 Dizon Romeo R Other SELL $5.86 2,806 $16,444 22,483 -11.1%
2017-12-16 03:06 2017-12-12 MOORE WILLIAM M Director, Officer - Chairman and CEO BUY $7.84 5,000 $39,200 83,944 +6.3%
2017-09-19 01:42 2017-09-15 MOORE WILLIAM M Director, Officer - Chairman and CEO BUY $9.42 1,800 $16,956 372,434 +0.5%
2017-03-17 00:28 2017-03-15 Dizon Romeo R Other SELL $13.16 2,811 $36,988 17,289 -14.0%
2016-11-18 02:59 2016-11-16 Dizon Romeo R Other OPT+S $16.04 584 $9,367 20,100 0.0%
2016-09-15 01:48 2016-09-12 Dizon Romeo R Other OPT+S $15.00 125 $1,875 20,100 0.0%
2016-09-08 02:47 2016-09-02 NAUMANN-ETIENNE RUEDIGER Director SELL $14.75 9,513 $140,349 64,433 -12.9%
2016-08-25 00:50 2016-08-23 Dizon Romeo R Other OPT+S $14.52 875 $12,708 20,100 0.0%
2016-08-23 00:02 2016-08-18 Dizon Romeo R Other OPT+S $13.52 7,896 $106,734 20,100 0.0%
SHOW ENTRIES

How to Interpret $IRIX Trades

Not every insider transaction in IRIDEX CORP is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $IRIX shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for IRIX

Insider activity data for IRIDEX CORP is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $IRIX, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.